BioCorRx Inc. Annual Cost of Revenue in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
BioCorRx Inc. quarterly/annual Cost of Revenue history and growth rate from 2013 to 2023.
  • BioCorRx Inc. Cost of Revenue for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
  • BioCorRx Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $14.7K, a 53.4% decline year-over-year.
  • BioCorRx Inc. annual Cost of Revenue for 2023 was $36K, a 136% increase from 2022.
  • BioCorRx Inc. annual Cost of Revenue for 2022 was $15.3K, a 160% increase from 2021.
  • BioCorRx Inc. annual Cost of Revenue for 2021 was $5.88K, a 93.9% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $36K +$20.7K +136% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $15.3K +$9.4K +160% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $5.88K -$90.1K -93.9% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-31
2020 $95.9K +$14.3K +17.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $81.7K -$89.3K -52.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $171K -$153K -47.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $324K +$148K +84.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-16
2016 $175K +$23.5K +15.4% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-05
2015 $152K -$69K -31.2% Jan 1, 2015 Dec 31, 2015 10-K 2017-04-13
2014 $221K +$60.8K +37.9% Jan 1, 2014 Dec 31, 2014 10-K 2016-04-14
2013 $160K Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.